Publication | Closed Access

Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells

Lung InflammationCell SignalingMedicineApoptosisCell DeathCancer Cell BiologyCell CycleCell BiologyTumor SuppressorCancer GeneticsLung Cancer CellsCancer BiologyRadiation OncologyCancer ResearchLung CancerTumor Biology